400 related articles for article (PubMed ID: 29176760)
21. Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant.
Rady HF; Dai G; Huang W; Shellito JE; Ramsay AJ
PLoS One; 2016; 11(2):e0148701. PubMed ID: 26844553
[TBL] [Abstract][Full Text] [Related]
22. Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen.
Péchiné S; Denève C; Le Monnier A; Hoys S; Janoir C; Collignon A
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):73-81. PubMed ID: 21707776
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
[TBL] [Abstract][Full Text] [Related]
24. Immune responses induced by Clostridium difficile.
Péchiné S; Collignon A
Anaerobe; 2016 Oct; 41():68-78. PubMed ID: 27108093
[TBL] [Abstract][Full Text] [Related]
25. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
26. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
[TBL] [Abstract][Full Text] [Related]
27. Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis.
Bameri Z; Asadi Karam MR; Habibi M; Ehsani P; Bouzari S
Microb Pathog; 2018 Jan; 114():99-106. PubMed ID: 29138084
[TBL] [Abstract][Full Text] [Related]
28. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
[TBL] [Abstract][Full Text] [Related]
29. Mucosal and systemic adjuvant effects of cholera toxin and Cry1Ac protoxin on the specific antibody response to HIV-1 C4/V3 peptides are different and depend on the antigen co-administered.
Esquivel-Pérez R; Moreno-Fierros L
Viral Immunol; 2005; 18(4):695-708. PubMed ID: 16359236
[TBL] [Abstract][Full Text] [Related]
30. Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization.
Zhang H; Liu L; Wen K; Huang J; Geng S; Shen J; Pan Z; Jiao X
Cell Mol Immunol; 2011 Nov; 8(6):496-501. PubMed ID: 21841816
[TBL] [Abstract][Full Text] [Related]
31. Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice.
Ghose C; Kalsy A; Sheikh A; Rollenhagen J; John M; Young J; Rollins SM; Qadri F; Calderwood SB; Kelly CP; Ryan ET
Infect Immun; 2007 Jun; 75(6):2826-32. PubMed ID: 17371854
[TBL] [Abstract][Full Text] [Related]
32. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of adhesion of Clostridium difficile to human intestinal cells after treatment with serum and intestinal fluid isolated from mice immunized with nontoxigenic C. difficile membrane fraction.
Senoh M; Iwaki M; Yamamoto A; Kato H; Fukuda T; Shibayama K
Microb Pathog; 2015 Apr; 81():1-5. PubMed ID: 25745878
[TBL] [Abstract][Full Text] [Related]
34. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
35. Vaccination against
Winter K; Xing L; Kassardjian A; Ward BJ
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31138615
[No Abstract] [Full Text] [Related]
36. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
37. Immunization using GroEL decreases Clostridium difficile intestinal colonization.
Péchiné S; Hennequin C; Boursier C; Hoys S; Collignon A
PLoS One; 2013; 8(11):e81112. PubMed ID: 24303034
[TBL] [Abstract][Full Text] [Related]
38. Chicken Immune Response after In Ovo Immunization with Chimeric TLR5 Activating Flagellin of Campylobacter jejuni.
Radomska KA; Vaezirad MM; Verstappen KM; Wösten MM; Wagenaar JA; van Putten JP
PLoS One; 2016; 11(10):e0164837. PubMed ID: 27760175
[TBL] [Abstract][Full Text] [Related]
39. Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with
Maia AR; Reyes-Ramírez R; Pizarro-Guajardo M; Saggese A; Ricca E; Baccigalupi L; Paredes-Sabja D
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933117
[No Abstract] [Full Text] [Related]
40. Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.
Monaris D; Sbrogio-Almeida ME; Dib CC; Canhamero TA; Souza GO; Vasconcellos SA; Ferreira LC; Abreu PA
Clin Vaccine Immunol; 2015 Aug; 22(8):965-73. PubMed ID: 26108285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
